Results from the first three rounds of the Scottish demonstration pilot of FOBT screening for colorectal cancer

Gut

Volumn 58, Issue 4, 2009, Pages 530-535

  Steele, R J C ^a,b,g   McClements, P L ^c   Libby, G ^b,c   Black, R ^c   Morton, C ^c   Birrell, J ^c   Mowat, N A G ^d   Wilson, J A ^e   Kenicer, M ^f   Carey, F A ^a   Fraser, C G ^b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b Scottish Bowel Screening Centre   (United Kingdom)

^c INFORMATION SERVICES DIVISION   (United Kingdom)

^d ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^e VICTORIA HOSPITAL   (United Kingdom)

^f NHS TAYSIDE   (United Kingdom)

^g UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GUAIAC;

ADENOMA; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; COLORECTAL CANCER; FEMALE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD TEST; POPULATION RESEARCH; PREDICTION AND FORECASTING; PRIORITY JOURNAL; UNITED KINGDOM;

AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DIAGNOSIS; FEASIBILITY STUDIES; FEMALE; GUAIAC; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NEOPLASM STAGING; OCCULT BLOOD; PATIENT ACCEPTANCE OF HEALTH CARE; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; PROGRAM EVALUATION; REAGENT KITS, DIAGNOSTIC; SCOTLAND; STATE MEDICINE;

EID: 63849168974     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2008.162883     Document Type: Article

References (23)

1. Mandel JS, Bond JH, Church JR, et al. Reducing mortality from colorectal cancer by screening for faecal occult blood. N Engl J Med 1993;328:1365-71.
2. Hardcastle JD, Chamberlain JO, Robinson MHE, et al. Randomised controlled trial of faecal occult blood screening for colorectal cancer. Lancet 1996;348:1472-7.
3. Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal occult blood test. Lancet 1996;348:1467-71.
4. Towler B, Irwig L, Glasziou P, et al. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, Hemoccult. Br Med J 1998;317:559-65.
5. Lindholm E, Brevinge H, Haglind E. Survival benefit in a randomised clinical trial of faecal occult blood screening for colorectal cancer. Br J Surg 2008;95:1029-36.
6. Steele RJC, Parker R, Patnick J, et al. A demonstration pilot for colorectal cancer screening in the United Kingdom: a new concept in the introduction of health care strategies. J Med Screen 2001;8:197-202.
7. UK Colorectal Cancer Screening Pilot Group. Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom. BMJ 2004;329:133-135.
8. Department of Health Press. Release 2003/0047 (http://www.info. doh.gov.uk/ doh/intpress.nsf/page/2003-0047).
9. NHS Scotland. Cancer in Scotland, action for change. Bowel Cancer Framework for Scotland, 2004.
10. Scottish Executive Health Department. HDL(2006)3. Bowel cancer screening programme. Edinburgh: SEHD, 2006.
11. Medical Devices Agency. Evaluation of eleven faecal occult blood test kits. MDA/ 2000/05. London: MDA, 2000.
12. Atkin WS, Saunders BP. Surveillance guidelines after removal of colorectal adenomatous polyps. Gut 2002;51 (Suppl v):v6-vv9.
13. Kewenter J, Brevinge H, Engaras B, et al. Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68,308 subjects. Scand J Gastroenterol 1994;29:468-73.
14. Faivre J, Dancourt V, Lejeune C, et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology 2004;126:1674-80.
15. Pignone M, Campbell MK, Carr C, et al. Meta-analysis of dietary restriction during fecal occult blood testing. Eff Clin Pract 2001;4:150-6.
16. Sinatra MA, St John DJ, Young GP. Interference of plant peroxidases with guaiac- based fecal occult blood tests is avoidable. Clin Chem 1999;45:123-6.
17. Allison JE. Colon cancer screening guidelines 2005: the fecal occult blood test option has become a better FIT [editorial]. Gastroenterology 2005;129:745-8.
18. Van Rossum LG, Van Rijn AF, Laheij RJ, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008;135:82-90.
19. Fraser CG, Matthew CM, Mowat NAG, et al. Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study. Lancet Oncol 2006;7:127-31.
20. Fraser CG, Matthew CM, Mowat NAG, et al. Evaluation of a card collection based faecal immunochemical test in screening for colorectal cancer using a two-tier reflex approach. Gut 2007;56:1415-8.
21. Roger J, Steele RJC. Telephone assessment increases uptake of colonoscopy in a FOBT colorectal cancer screening programme. J Med Screening (in press).
22. Weller D, Coleman D, Robertson R, et al. The UK colorectal cancer screening pilot: results of the second round of screening in England. Br J Cancer 2007;97:1601-5.
23. Rowan S, Brewster D. Colorectal. In: Quinn M, Wood, H, Cooper N, Rowan S, eds. Cancer atlas of the United Kingdom 1991-2000. London: Palgrave Macmillan, 2005:80-90.